Article Sidebar
Published:
Feb 7, 2022Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Effect of oxymatrine on hypoxic-ischemic brain injury in neonatal rats
Abstract
Purpose: To study the influence of oxymatrine on hypoxic-ischemic brain injury (HIBI) in neonatal rats.
Methods: Newborn SPF Sprague-Dawley (SD) rats were randomly assigned to 3 groups (10 rats/group): control, HIBI and oxymatrine groups. Neurobehavioral latency of each rat was determined after 48 h of treatment, and pathological changes in rat cerebral cortex were evaluated using H&E staining. Hippocampal neurons prepared from rat brain tissue were grouped and treated as per the above in vivo study. Cell survival and neuronal apoptotic changes were measured with CCK-8 and flow cytometric analysis, respectively, while protein expressions of bcl-2, mcl-1, bax, caspase-3, PI3K, p- PI3K, Akt, p-Akt, GSK3β and p-GSK3β were determined with Western blotting.
Results: Treatment of HIBI rats with oxymatrine significantly reduced their neurobehavioral latencies (reflex, cliff avoidance reflex, and negative reflex (latencies), but repaired HIBI-induced histological damage in rat cerebral cortex (p < 0.05). It also significantly enhanced the survival of rat hippocampal neurons, while reducing neuronal apoptosis (p < 0.05). Moreover, oxymatrine significantly upregulated bcl-2, mcl-1, p-PI3K, AKT, p-AKT, GSK3β and p-GSK3β protein expressions, but i significantly downregulated the protein expressions of bax and caspase-3 in cerebral cortex of HIBI rat (p < 0.05).
Conclusion: These results indicate that oxymatrine reduces neuronal apoptosis and alleviates HIBI in rats via the regulation of proteins associated with PI3K/Akt/GSK3β signal pathway. This finding provides a new research direction on novel botanical monomers for treating HIBI.
